Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?
In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff
Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time
CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years
Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates
NCI Programs: Pediatric Brain Tumor Grants Awarded
Trending Stories
- In the Headlines: What’s in Trump’s draft budget?
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same
- Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health
- Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas - Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI